KNSA
$83.17+4.64%
Kiniksa Pharmaceuticals International plcStock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.008% of ONEQUS Stock Market · 0.004% of VTIRussell 3000 · 0.004% of IWV
KNSA financial statements
The full income statement, balance sheet, and cash-flow statement for Kiniksa Pharmaceuticals International plc (KNSA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 71.1M2024-09 72.2M2024-12 72.5M2025-03 72.8M2025-06 74.0M2025-09 75.4M2025-12 76.3M2026-03 76.7M2026-06 78.0M+9.7% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 678M+60.1% | 423M+56.6% | 270M+22.7% | 220M+471.2% | 38.5M | |
| Cost of revenue | 77.7M+27.5% | 60.9M+82.3% | 33.4M+45.9% | 22.9M+151.6% | 9.10M | |
| Research & development | 96.9M-13.2% | 112M+46.7% | 76.1M+16.2% | 65.5M-34.0% | 99.3M-11.4% | |
| Selling, general & administrative | 196M+16.8% | 168M+29.8% | 129M+32.1% | 98.0M+14.0% | 85.9M+89.6% | |
| Operating income | 77.2M+269.3% | -45.6M-81.0% | -25.2M-357.8% | 9.77M+106.2% | -157M+0.5% | |
| Interest & investment income | 11.6M+28.8% | 9.04M+9.8% | 8.23M+568.9% | 1.23M+1168.0% | 97.0K-91.4% | |
| Pre-tax income | 88.9M+345.8% | -36.2M-117.1% | -16.7M-251.0% | 11.0M+107.0% | -157M-0.2% | |
| Income tax | 29.9M+324.1% | 7.04M+122.9% | -30.7M+82.2% | -172M-12543.1% | 1.39M-73.1% | |
| Net income | 59.0M+236.6% | -43.2M-406.7% | 14.1M-92.3% | 183M+216.1% | -158M+2.1% | |
| $0.75+225.0% | -$0.60-400.0% | $0.20-92.3% | $2.60+213.0% | -$2.30+11.9% | ||
| EPS (basic) | $0.80+233.3% | -$0.60-400.0% | $0.20-92.4% | $2.64+214.8% | -$2.30+11.9% | |
| Weighted-avg shares (basic) | 74.2M+3.9% | 71.4M+1.9% | 70.1M+1.0% | 69.4M+1.2% | 68.6M+10.9% | |
| Weighted-avg shares (diluted) | 79.0M+10.6% | 71.4M-0.7% | 71.9M+2.1% | 70.4M+2.7% | 68.6M+10.9% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 527M+58.9% | 332M+20.1% | 276M+13.7% | 243M+23.7% | 196M-41.1% | ||
| Cash & equivalents | 166M-9.8% | 184M+70.1% | 108M-12.0% | 123M+0.2% | 122M+7.4% | |
| Short-term investments | 248M+313.8% | 60.0M-39.0% | 98.4M+45.0% | 67.9M+13.7% | 59.7M-71.5% | |
| Cash & short-term investments | 414M+70.0% | 244M+18.1% | 206M+8.3% | 191M+4.6% | 182M-43.7% | |
| Accounts receivable | 15.6M-62.6% | 41.7M+96.2% | 21.3M+68.0% | 12.7M+217.7% | 3.98M | |
| Inventory | 54.9M+108.2% | 26.4M-15.3% | 31.1M+44.1% | 21.6M+487.7% | 3.67M | |
| Prepaid expenses | 42.6M+112.2% | 20.1M+14.5% | 17.5M+66.4% | 10.5M+60.0% | 6.58M-31.1% | |
| 764M+31.5% | 581M+10.3% | 526M+14.5% | 460M+97.5% | 233M-33.4% | ||
| Property, plant & equipment | 1.94M+193.5% | 662K-9.8% | 734K-55.7% | 1.66M-41.5% | 2.83M-30.0% | |
| Operating lease right-of-use | 9.81M-5.5% | 10.4M-13.0% | 11.9M+121.6% | 5.38M-3.0% | 5.55M-15.5% | |
| Intangible assets | 15.3M-6.2% | 16.3M-5.8% | 17.3M-5.5% | 18.3M-5.2% | 19.3M | |
| Deferred tax assets | 198M-6.2% | 211M-3.7% | 219M+18.2% | 185M | — | |
| Other non-current assets | 11.3M+9.6% | 10.3M+1147.3% | 827K-85.8% | 5.82M-33.2% | 8.72M+56.0% | |
| 139M+38.3% | 101M+58.0% | 63.7M+35.3% | 47.1M+5.0% | 44.8M+40.8% | ||
| Accounts payable | 2.03M-0.5% | 2.04M-75.3% | 8.25M+4.4% | 7.90M+322.9% | 1.87M+271.4% | |
| Accrued liabilities | 42.0M+29.9% | 32.4M+16.7% | 27.7M-7.9% | 30.1M-20.8% | 38.0M+30.2% | |
| Deferred revenue | — | — | 307K | — | — | |
| Current lease liability | 2.99M+49.9% | 1.99M-11.5% | 2.25M-31.7% | 3.30M-2.4% | 3.38M+60.5% | |
| Other current liabilities | 22.1M+37.7% | 16.1M+96.2% | 8.19M+42.4% | 5.75M+272.7% | 1.54M+4073.0% | |
| 196M+37.9% | 142M+62.5% | 87.5M+37.7% | 63.5M+33.0% | 47.8M+27.3% | ||
| Deferred revenue (non-current) | 31.8M+0.0% | 31.8M+166.1% | 12.0M-0.4% | 12.0M | — | |
| Non-current lease liability | 6.51M-17.2% | 7.86M-21.4% | 10.0M+282.2% | 2.62M-1.9% | 2.67M-45.3% | |
| Operating lease liability (total) | 9.50M-3.6% | 9.86M | — | 5.92M-2.2% | 6.05M-13.4% | |
| Other non-current liabilities | 18.5M+916.0% | 1.82M-1.9% | 1.86M+1.0% | 1.84M+581.1% | 270K-66.5% | |
| 568M+29.5% | 438M-0.1% | 439M+10.8% | 396M+114.1% | 185M-40.7% | ||
| Additional paid-in capital | 1.03B+7.3% | 960M+4.7% | 917M+3.2% | 888M+3.2% | 860M+3.7% | |
| Retained earnings | -462M+11.3% | -521M-9.0% | -478M+2.9% | -492M+27.1% | -675M-30.5% | |
| Accumulated other comprehensive income | -25.0K+84.7% | -163K-2816.7% | 6.00K-86.4% | 44.0K+166.7% | -66.0K-94.1% | |
| Total liabilities & equity | 764M+31.5% | 581M+10.3% | 526M+14.5% | 460M+97.5% | 233M-33.4% | |
| Common shares outstanding | 76.3M+5.2% | 72.5M+2.9% | 70.5M+1.1% | 69.7M+0.9% | 69.1M+1.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 138M+437.1% | 25.7M+93.1% | 13.3M+129.1% | 5.81M+104.6% | -126M+7.5% | ||
| Depreciation & amortization | 1.55M-8.3% | 1.70M-27.6% | 2.34M-2.5% | 2.40M+2.0% | 2.35M-2.1% | |
| Share-based compensation | 37.0M+20.6% | 30.7M+13.1% | 27.1M+8.1% | 25.1M-0.2% | 25.2M+20.6% | |
| Deferred income taxes | 13.0M+59.9% | 8.13M+124.1% | -33.8M+81.8% | -185M-1686418.2% | 11.0K-99.7% | |
| Change in receivables | -26.1M-227.7% | 20.5M+137.7% | 8.61M-0.8% | 8.68M+121.9% | 3.91M | |
| Change in inventory | 28.5M+699.6% | -4.76M-150.0% | 9.52M-46.9% | 17.9M+387.7% | 3.67M | |
| Change in payables | 142K+102.3% | -6.31M-1917.3% | 347K-94.2% | 6.03M+341.5% | 1.37M+127.5% | |
| -189M-601.7% | 37.7M+227.5% | -29.6M-265.9% | -8.08M-106.3% | 129M+648.7% | ||
| Capital expenditure | 1.57M+466.1% | 277K+113.1% | 130K+23.8% | 105K-74.7% | 415K+46.6% | |
| Free cash flow | 136M+436.8% | 25.4M+92.9% | 13.2M+131.0% | 5.70M+104.5% | -127M+7.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | — | 25.0K | — | 91.0K | — | |
| 33.0M+169.2% | 12.3M+720.5% | 1.50M-40.6% | 2.52M-57.2% | 5.88M-97.4% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Income taxes paid | 3.01M+50.4% | 2.00M-64.3% | 5.61M-47.6% | 10.7M+735.7% | 1.28M+165.4% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 3.15B+119.4% | 1.43B+16.3% | 1.23B+18.4% | 1.04B+28.1% | 813M-32.6% | |
| P/E | 53.3× | — | — | 7.3× | — | |
| P/S | 4.6×+37.1% | 3.4×-31.6% | 5.0×-15.7% | 5.9×-72.1% | 21.1× | |
| P/B | 5.5×+69.5% | 3.3×+7.5% | 3.0×+12.3% | 2.7×-38.3% | 4.4×+13.7% | |
| P/FCF | 23.1×-59.1% | 56.4× | — | — | — | |
| Earnings yield | 1.9% | — | — | 13.7% | — | |
| FCF yield | 4.3%+144.7% | 1.8% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: KNSA’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all KNSA filings on SEC EDGAR → Not investment advice.